Concepedia
Publication | Open Access
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression
261
Citations
3
References
2020
Year
ClinicalTrials.gov identifier: NCT02497287.
Page 1